Public Health@Cambridge Network and Hughes Hall are hosting a one day interdisciplinary conference bringing together current Cambridge research relevant to the processes and contexts of ageing.

In this event, representatives from Johnson & Johnson Innovation will provide an overview of goals and missions, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development. Following the presentation, the Johnson & Johnson Innovation team will meet one-on-one with early-stage companies and […]

A new monthly seminar series starting in 2020. Talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. This week's speakers are Ludovic Vallier (Wellcome MRC  Cambridge Stem Cell Institute) & Pal Mander (GlaxoSmithKline)

This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and pioneering applications in therapeutic genome editing.

Will include presentations on a device to enhance fine motor skills, new ways to monitor blood glucose, and a spinal neurostimulation implant. Medical i-Teams investigate the best applications and routes to market for new university inventions, by interviewing relevant experts, clinicians and patient advocates.

The March meeting of the Cambridge New Therapeutics Forum (CamNTF) is now open for registration. This meeting will be hosted by the Cambridge Alliance on Medicines Safety and we are delighted to be holding this event at the newly-opened Jeffrey Cheah Biomedical Centre - home of The Milner Therapeutics Institute.

An interdisciplinary conference on the research, practice and education of global health. Keynote address by Dame Sally Davies. Organised by Cambridge Global Health Partnerships in collaboration with the PublicHealth@Cambridge Network at the Cambridge Institute of Public Health

The 2020 ELRIG Research & Innovation conference will discuss how the most promising new biology is being identified and explore emerging technologies and innovations to enable this science to be translated into successful therapeutics.

POSTPONED The organising committee for the C2D3 Research Symposium, 22 April 2020, have taken the decision to postpone the event due to Covid-19.

Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. Talks will be available online all day, with a live Q&A at 1pm. This week's speaker is Mathew Garnett, from the Wellcome Sanger Institute: "Functional genomics approaches to guide cancer drug discovery"   You can now access Mathews's talk using the […]

A series of webinars covering the drug discovery process, from the experts at Medicines Discovery Catapult (MDC) and CRO network partners.

Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. Available now! The Talk: This talk is now live using the credentials below. Waradon Sungnak (Wellcome Sanger Institute) “Single-Cell Transcriptomics Analysis of SARS-CoV-2 Entry Factors” Click here » Password: 6c$0012^ The QA&: Thank you to everyone who joined in for our […]

Hosted by Dr Nicholas Matheson, CITIID PI and consultant in Infectious Diseases. Each episode includes an update on the evolving COVID-19 pandemic, and a review of the latest developments in SARS-CoV-2 biomedical research and experimental medicine.

Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. The talk is now available to view by clicking this link » A live Q&A session will take place at 1pm BST, on Thursday 21st May. Click here » Password: 2tzuwE*JUJ Our speaker will be Robin Franklin, from the Wellcome MRC Cambridge […]

Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. Our speaker will be Jason Carroll, from the Wellcome MRC Cambridge Stem Cell Institute. The Talk: "Mechanisms of estrogen receptor activity in breast cancer" Click here » *Please note that the sound glitching midway through this recording quickly resolves* The Q&A: Click here » […]

In light of the ongoing situation around COVID-19, the 2020 Symposium has been moved online in a series of independent events starting on 12th June 2020. Each online event is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new […]

Includes an expanded programme on how to transform new medicine discovery, live debates and pre-recorded insight sessions on technology and innovation, keynote Presentations and Fireside Chats with international Key Opinion Leaders, workshop sessions on key business challenges

In light of the COVID-19 pandemic, the International Brain Tumour Summer school will be rescheduled for summer, 2021.

In this second talk, participants will be introduced to CATS' new Expert in Residence(EiR) Adrian Alexa. Alexa’s area of expertise lies in data science, bioinformatics and software development. More details will follow shortly on the CATS website.